A randomized, phase Ib trial of recombinant human serum albumin in cirrhotic patients with ascites

Xinrui Wang, Yanhang Gao(Jilin University), Huifan Ji(Jilin University), Zhengwei Fu(Zhejiang University of Science and Technology), Jinglan Jin(Jilin University), Yulin Hu(Jilin University), Runping Gao(Jilin University), Wei Xiang(Friedrich-Alexander-Universität Erlangen-Nürnberg), Wanyu Li(Harvard University), Yifei Wang(Beijing University of Technology), Guijie Xin(First Bethune Hospital of Jilin University), Chong Wang(Jilin University), Siqi Wang(Tonghua Normal University), Yu Pan(Shanghai Jiao Tong University), Zhongfeng Wang(Fudan University), Fang Xu(Jilin University), Yu Ge(Tianjin University of Science and Technology), Yanjun Cai(Jilin University), Hongxin Piao(Yanbian University Hospital), Xiaoyu Wen(Jilin University), Qinglong Jin(Jilin University), Fei Kong(Shanghai Jiao Tong University), Xu Li(Hangzhou Hospital of Traditional Chinese Medicine), Rui Hua(Jilin University), Yue Qi(Anhui Medical University), Qiang Zhou(Nanjing Drum Tower Hospital), Tao Yang(Jiangsu University), Xiaolin Guo(Peking University), Junqi Niu(Jilin University)
Hepatology International
July 23, 2025
Cited by 3


Related Papers